MediPharm Labs Enters United States Pharmaceutical Market with Submission of FDA DMF
February 23, 2022
Ryan Allway February 23rd, 2022 News, Top News Completed a Drug Master File (“DMF”) process for CBD Active Pharmaceutical Ingredient (“API”) for the US Federal Drug Administration (“FDA”). Use of Canadian Drug Establishment Licence (“DEL”) to register API with the FDA for commercial opportunities in pharmaceutical development, novel drugs... Read more
Turning Point Brands Signs Distribution Agreement for Leading Global Lighter Brand CLIPPER®
February 22, 2022
Ryan Allway February 22nd, 2022 News, Top News Deal Includes Exclusive Distribution Rights for CLIPPER® Lighters in the U.S. and Canada LOUISVILLE, Ky., February 22, 2022–(BUSINESS WIRE)–Turning Point Brands, Inc. (“TPB” or “the Company”) (NYSE: TPB), a manufacturer, marketer and distributor of branded consumer products, including alternative smoking accessories and... Read more
LEADING CANNABIS RETAIL AND LIFESTYLE BRAND SUPERETTE ACQUIRES CANNOE ESTABLISHING ITSELF AS CANADA’S LEADING INDEPENDENT RETAILER
February 22, 2022
Ryan Allway February 22nd, 2022 News, Top News TRANSACTION DOUBLES SUPERETTE’S RETAIL FOOTPRINT AND PROVIDES $5M FUEL FOR GROWTH Toronto, Canada, Feb. 22, 2022 (GLOBE NEWSWIRE) — Today Superette Inc. (“Superette” or the “Company”) announces the acquisition of Cannoe Corp. (“Cannoe”) and concurrent $5M financing in a transformative transaction... Read more
Elixxer Ltd. Announces Amended Secured Loan with AIP Convertible Private Debt Fund L.P.
February 22, 2022
Ryan Allway February 22nd, 2022 News, Top News Montreal, Quebec–(Newsfile Corp. – February 22, 2022) – Elixxer Ltd. (TSXV: ELXR) (OTCQB: ELIXF) (“Elixxer” or the “Company) is pleased to announce that it has entered into an agreement with AIP Convertible Private Debt Fund L.P. (“AIP“) to amend its existing... Read more
AYURCANN Holdings CORP. Reports Record Sales And Fourth Consecutive Quarter Of Positive Operating Income
February 22, 2022
Ryan Allway February 22nd, 2022 News, Top News Toronto, Ontario, Feb. 22, 2022 (GLOBE NEWSWIRE) — Ayurcann Holdings Corp. (CSE:AYUR, OTCQB:AYURF, FSE:3ZQ0) (“Ayurcann” or the “Company”), a leading Canadian cannabis extraction company specializing in the processing and co-manufacturing of pharma grade cannabis and hemp to produce various derivative cannabis 2.0 and 3.0 products... Read more
Applied DNA Announces Pricing of $4.2 Million Registered Direct Offering
February 22, 2022
Ryan Allway February 22nd, 2022 News, Top News STONY BROOK, N.Y., February 22, 2022–(BUSINESS WIRE)–Applied DNA Sciences, Inc. (NASDAQ: APDN) (the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, announced today that it has entered into a securities purchase agreement with an institutional investor, providing for the... Read more
Eve & Co Announces Closing of Shares for Debt Transaction
February 18, 2022
Ryan Allway February 18th, 2022 News, Top News STRATHROY, Ontario, Feb. 18, 2022 (GLOBE NEWSWIRE) — Eve & Co Incorporated (“Eve & Co” or the “Company”) (TSX-V: EVE; OTCQX: EEVVF) is pleased to announce it has closed its previously announced shares for debt transaction (the “Transaction”) whereby it settled... Read more
Cara Therapeutics to Host Virtual R&D Day on March 11, 2022
February 18, 2022
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any... Read more
Curaleaf Expands Pennsylvania Retail Presence with Dispensary Openings in State College and Erie
Pennsylvania February 18, 2022
Ryan Allway February 18th, 2022 News, Top News Newest Dispensaries Expand Company’s Retail Presence to 16 Locations in Fast Growing Pennsylvania Medical Market, and 127 Nationwide WAKEFIELD, Mass., Feb. 18, 2022 /PRNewswire/ — Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) (“Curaleaf” or the “Company”), a leading international provider of consumer products in... Read more
Ryan Allway February 17th, 2022 Psychedelics, Top News TORONTO, February 17, 2022–(BUSINESS WIRE)–Biomind Labs Inc. (“Biomind Labs” or the “Company“) (NEO: BMND) (OTC: CRSWF) (FSE: 3XI), a leading biotech company focused on innovation and research on endogenous tryptamines (biomolecules acting as psychoneuroplastogens) for the treatment of mental health disorders and... Read more
